![James Meyers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Meyers
Direktor/Vorstandsmitglied bei
CYTOMX THERAPEUTICS, INC.
Vermögen: 5 378 $ am 30.06.2026
Profil
James R.
Meyers is currently Chairman at IntegriChain, Inc. since 2024.
He serves as Independent Director at Sangamo Therapeutics, Inc. since 2019, Director at Biotechnology Innovation Organization, Director at Pulmocide Ltd., Independent Director at CytomX Therapeutics, Inc. since 2018, Director at California Biomedical Innovation Alliance, and Independent Director at Vera Therapeutics, Inc. starting in 2025.
Former roles include President & Chief Executive Officer at IntraBio, Inc. from 2020 to 2024, Independent Director at Arbutus Biopharma Corp.
from 2018 to 2025, and Executive VP-Worldwide Commercial Operations at Gilead Sciences, Inc. from 2016 to 2018.
Education includes undergraduate studies at Boston College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.06.2025 | 99’600 ( 0.02% ) | 5 378 $ | 30.06.2026 | |
| 17.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 | |
| 21.05.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von James Meyers
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 20.12.2018 |
| SANGAMO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 22.11.2019 |
| VERA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 25.11.2025 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | - |
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Direktor/Vorstandsmitglied | - |
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops inhaled medicines for viral and fungal infections of the respiratory diseases | Direktor/Vorstandsmitglied | - |
IntegriChain, Inc.
 IntegriChain, Inc. Packaged SoftwareTechnology Services Develops data-driven commercialization platform for pharma manufacturers | Vorsitzender | 01.03.2024 |
Ehemalige bekannte Positionen von James Meyers
| Unternehmen | Position | Ende |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Direktor/Vorstandsmitglied | 24.02.2025 |
IntraBio, Inc.
 IntraBio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel drugs | Vorstandsvorsitzender | 01.01.2024 |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von James Meyers
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IntegriChain, Inc.
IntegriChain, Inc. Packaged SoftwareTechnology Services Develops data-driven commercialization platform for pharma manufacturers | Technology Services |
Pulmocide Ltd.
Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops inhaled medicines for viral and fungal infections of the respiratory diseases | Health Technology |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
California Biomedical Innovation Alliance
California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Health Technology |
IntraBio, Inc.
IntraBio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel drugs | Health Technology |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Wählen Sie MarketScreener 
